Institute of Naval Medicine, Alverstoke, Gosport, Hants PO12 2DL, UK.
J Psychopharmacol. 1989 Jan;3(4):187-97. doi: 10.1177/026988118900300401.
Investigations into antimotion sickness drugs fall into two main categories: efficacy ('benefits') and side-effects ('costs'). This study was of the second type. Oral cinnarizine (30 mg: normal dose; and 75 mg: 2.5 x normal dose) and placebo, were investigated using a battery of automated mental, motor, physiological and other tests in twelve young healthy male volunteers. The higher cinnarizine dose level was chosen to exaggerate effects and make it easier to track them. Oral hyoscine (1.2 mg: 2 x normal dose) was employed as a positive internal control. Side-effects were almost exclusively due to hyoscine whereas cinnarizine was almost free of significant effects even at the higher dose of 75 mg. Hyoscine impaired performance 1-3 hours postdrug, whereas the effects of cinnarizine occurred approximately 5-7 hours postdrug. This paralleled the slower time-course for the protective action of cinnarizine against motion sickness noted in earlier studies. These results, taken in conjunction with previous trials, suggest that oral cinnarizine would seem less likely than hyoscine to produce unwanted decrements in performance.
疗效(“益处”)和副作用(“成本”)。本研究属于第二类。我们在 12 名年轻健康男性志愿者中使用一系列自动化的精神、运动、生理和其他测试,对口服肉桂嗪(30 毫克:正常剂量;75 毫克:正常剂量的 2.5 倍)和安慰剂进行了研究。选择更高的肉桂嗪剂量水平是为了夸大效果,以便更容易追踪。口服氢溴酸东莨菪碱(1.2 毫克:正常剂量的 2 倍)用作阳性内部对照。副作用几乎完全是由东莨菪碱引起的,而肉桂嗪即使在较高的 75 毫克剂量下也几乎没有显著的影响。氢溴酸东莨菪碱在用药后 1-3 小时内会影响表现,而肉桂嗪的作用则在用药后 5-7 小时左右发生。这与之前的研究中观察到的肉桂嗪对运动病的保护作用的较慢时间过程相吻合。这些结果与之前的试验相结合,表明口服肉桂嗪不太可能像氢溴酸东莨菪碱那样导致性能出现不必要的下降。